A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases.
Graduate school alumni have been recognized with this award since 1997 for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to society.
The Weill Cornell Graduate School of Medical Sciences honored the Class of 2020 for their academic achievements during a virtual convocation ceremony on May 27. Students and their families and friends watched a livestream of the event, as graduate school faculty announced the recipients of special awards and prizes.
The prospect of residency typically brings jitters to newly minted doctors as they prepare to start the next phase of their medical training, and the level and scope of their patient care responsibilities increases. But the transition has become far more complex with numerous unknowns surrounding the ongoing COVID-19 pandemic.
The fourth annual NYC Health Hackathon brought together students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus and several local and national academic institutions, to develop high-tech healthcare innovations.
Urinary tract infections (UTIs) in kidney transplant patients may be caused by bacteria that originate in the digestive tract, according to investigators at Weill Cornell Medicine, Cornell University and NewYork-Presbyterian.
A common variation in a human gene that affects the brain’s reward processing circuit increases vulnerability to the rewarding effects of the main psychoactive ingredient of cannabis in adolescent females, but not males.
The scope of the DNA changes that drive cancers has been illuminated as never before in a set of studies by a large international scientific team including Weill Cornell Medicine researchers. In six studies published Feb. 5 in Nature, and 18 papers in other Nature-affiliated journals, this scientific consortium reported the results from analyses of DNA from more than 2,600 biopsied tumor samples across 38 different types of cancer.
Molecules that coordinate the development of highly specialized blood vessels in the kidney have been identified by investigators at Weill Cornell Medicine, University of Texas Southwestern Medical Center and Hofstra University. The findings pave the way toward new strategies for repairing damaged organs.
An inexpensive program using trained community members to deliver a structured program based on cognitive behavioral therapy by telephone was able to improve daily functioning, self-reported physical activity, and overall quality of life among diabetic patients with chronic pain.
Dr. Tan A. Ince has been named chief of pathology at NewYork-Presbyterian Brooklyn Methodist Hospital, effective February 1. Dr. Ince was also recruited to Weill Cornell Medicine as a professor of pathology and laboratory medicine.
Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.